Pancrelipase: Clinical Trials

47 trials of Pancrelipase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 11 terminated, 4 recruiting, 3 withdrawn. 14 Phase 4, 13 Phase 2, 8 Phase 3, 6 Not applicable, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 414Completed 7, Terminated 4, Withdrawn 2, Recruiting 1
Phase 213Completed 4, Active not recruiting 2, Recruiting 2, Terminated 2, Unknown 2, Withdrawn 1
Phase 38Completed 6, Unknown 2
Not applicable6Completed 4, Recruiting 1, Terminated 1
Phase 16Terminated 4, Active not recruiting 1, Completed 1
Early Phase 11Completed 1

Follow Pancrelipase: new trials by email Literature Review of Pancrelipase trials Research Report on Pancrelipase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
NHS7108, Zenpep® - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2RecruitingAimmune Nestlé Health Science US R&D, LLC662026-10-012026-10-01
Phase 2 Study to Assess the Safety and Efficacy of ANG003
ANG003 Dose A, ANG003 Dose B, Creon - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2RecruitingAnagram Therapeutics, Inc.1132026-04-242026-10-30
Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)
Zenpep, Placebo - Malnutrition
Not applicableRecruitingPhilipp Schuetz202025-09-222026-09-22
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
Pancrelipase Capsules - Exocrine Pancreatic Insufficiency
Phase 4RecruitingOhio State University302024-02-012026-06-10
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
Pertzye - Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer
Phase 1 / Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center172022-11-302026-02-25
Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes
CREON, Placebo - Type 1 Diabetes
Early Phase 1CompletedVanderbilt University Medical Center112022-09-022025-03-28
Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon
CREON - Cystic Fibrosis, Chronic Pancreatitis
Phase 4CompletedAbbVie302021-10-142024-07-23
Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
CREON - Chronic Pancreatitis
CompletedAbbVie632021-09-162024-03-28
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
Pancreatic Enzyme, Ursodeoxycholic acid, Pancreatic Enzyme placebo - SEPSIS, MALNUTRITION, CHILD
Phase 2 / Phase 3UnknownUniversity of Oxford4002021-07-012023-02-24
Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
Pancrelipase - Pancreatic Adenocarcinoma
Phase 2Active not recruitingAndrew Hendifar, MD362020-12-172026-01-23
Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer
CREON - Exocrine Pancreatic Insufficiency (EPI)
Phase 4WithdrawnAbbVie2020-05-062021-11-08
A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
Pancrelipase, Placebo - Exocrine Pancreatic Insufficiency (EPI)
Phase 4TerminatedAbbVie12020-02-252023-06-05
A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Pancrelipase - Cystic Fibrosis
Phase 4CompletedAbbVie362019-10-232023-09-28
Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma
Pancrelipase - Pancreatic Cancer
Phase 2TerminatedDana-Farber Cancer Institute42018-04-132020-08-03
Use of Pancreatic Enzymes in Short Bowel Syndrome
Pancreatic Enzyme - Short Bowel Syndrome
Phase 2CompletedChildren's Hospital of Philadelphia162017-03-242020-03-20
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Pancrelipase, Placebo Oral Capsule - Pancreatic Insufficiency, Pancreatic Cancer
Phase 1 / Phase 2TerminatedMassimo Raimondo, M.D.162016-12-012021-03-15
Fat Malabsorption in Chronic Pancreatitis
Creon36™ - Chronic Pancreatitis
Phase 2CompletedChildren's Hospital of Philadelphia482016-10-132019-05-03
Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis
Pancrelipase, placebo - Pancreatitis
Phase 2WithdrawnDartmouth-Hitchcock Medical Center2016-04-012018-02-27
Pancreatic Enzyme Supplementation for Celiac Disease
pancrelipase - Celiac Disease
Phase 4TerminatedBeth Israel Deaconess Medical Center212015-05-012021-05-12
Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Creon IR, Creon® (DR/GR) - Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
Phase 2CompletedAbbott702015-03-012016-04-04

Showing 20 of 47. Sign in to see all of them.

Conditions studied

Exocrine Pancreatic Insufficiency (30)  ·  Cystic Fibrosis (13)  ·  Pancreatitis, Chronic (9)  ·  Pancreatic Neoplasms (4)  ·  Pancreatitis (3)  ·  Malnutrition (2)  ·  Pancreatic Diseases (2)  ·  Steatorrhea (2)  ·  Abdominal Pain (1)  ·  Celiac Disease (1)  ·  Cerebral Palsy (1)  ·  Child Nutrition Disorders (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diarrhea (1)  ·  Digestive System Diseases (1)

Sponsors

AbbVie (6)  ·  Forest Laboratories (6)  ·  Abbott (3)  ·  Digestive Care, Inc. (3)  ·  Children's Hospital of Philadelphia (2)  ·  Abbott Products (1)  ·  Aimmune Nestlé Health Science US R&D, LLC (1)  ·  American Academy of Family Physicians (1)  ·  Anagram Therapeutics, Inc. (1)  ·  Andrew Hendifar, MD (1)  ·  Axcan Pharma (1)  ·  Azidus Brasil (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Dana-Farber Cancer Institute (1)  ·  Dartmouth-Hitchcock Medical Center (1)

Countries

United States (30)  ·  Hungary (4)  ·  Italy (4)  ·  Spain (4)  ·  Bulgaria (3)  ·  Germany (3)  ·  Poland (3)  ·  United Kingdom (3)  ·  France (2)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Czechia (1)  ·  Japan (1)  ·  Kenya (1)

Top investigators

Suntje Sander-Struckmeier, PhD (3)  ·  Andrew Hendifar, MD, MPH (1)  ·  Arthur James Moser, MD (1)  ·  Babette Zemel, PhD (1)  ·  Christopher Taylor, MD, PhD (1)  ·  Ciaran Kelly, MD (1)  ·  Craig Peterson (1)  ·  Daniel Moore, MD, PhD (1)  ·  David S Sanders, FRCP (1)  ·  Eileen O'Reilly, MD (1)  ·  Gerard Mullin, MD (1)  ·  Guenter Krause, MD (1)

Results publications

PMID 32761612, PMID 27013382, PMID 34030986, PMID 35622082, PMID 36687454, PMID 37880023, PMID 42643234

NIH funding

2005 (1), 2009 (1), 2014 (1), 2017 (1), 2025 (1), UL1TR001082 (1)